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Background: Lung alveolar epithelial cell (AEC) apoptosis has attracted attention as an early pathogenic event in
the development of idiopathic interstitial pneumonia (IIP); however, the causative mechanism remains unclear.
Cell adhesion molecule 1 (CADM1) is an AEC adhesion molecule in the immunoglobulin superfamily. It generates a
membrane-associated C-terminal fragment, αCTF, through protease-mediated ectodomain shedding, termed
α-shedding. Increased CADM1 α-shedding contributes to AEC apoptosis in emphysematous lungs.
Methods: Formalin-fixed, paraffin-embedded lung lobes (n = 39) from 36 autopsied patients with IIP were
classified as acute IIP (n = 10), fibrosing-type nonspecific IIP (f-NSIP, n = 10), cryptogenic organizing IIP (n = 9),
and usual IIP (n = 10). CADM1 expression in the lung sections was examined by western blotting and compared
with control lungs (n = 10). The rate of CADM1 α-shedding was calculated as the relative amount of αCTF to
full-length CADM1, and the full-length CADM1 level was estimated per epithelial cell by normalization to
cytokeratin 7, a lung epithelial marker. Apoptotic AECs were detected by immunohistochemistry for single-stranded
DNA (ssDNA). NCI-H441 and A549 human lung epithelial cells were transfected with small interfering RNA (siRNA) to
silence CADM1 expression and analyzed by terminal nucleotide nick end labeling assays.
Results: The rate of CADM1 α-shedding was higher in all IIP subtypes than in the control (P ≤ 0.019), and the
full-length CADM1 level was lower in f-NSIP (P = 0.007). The α-shedding rate and full-length CADM1 level were
correlated with each other (P = 0.015) and with the proportion of ssDNA-positive AECs (P ≤ 0.024). NCI-H441 cells
transfected with siRNA exhibited a 61 % lower rate of expression of full-length CADM1 and a 17-fold increased
proportion of apoptotic cells. Similar results were obtained with A549 cells.
Conclusions: CADM1 α-shedding appeared to be increased in all four IIP subtypes and consequently contributed to
AEC apoptosis by decreasing the full-length CADM1 level. This mechanism particularly impacted f-NSIP. The molecular
mechanism causing AEC apoptosis may be similar between IIP and emphysema.
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Idiopathic interstitial pneumonias (IIPs) are a diverse
group of diffuse parenchymal lung diseases of unknown
etiology characterized by various degrees of acute or
chronic inflammation and progressive fibrosis of the lung
parenchyma. IIPs comprise several entities, including acute
interstitial pneumonia (AIP), nonspecific interstitial pneu-
monia (NSIP), cryptogenic organizing pneumonia (COP),
and usual interstitial pneumonia (UIP) or idiopathic
pulmonary fibrosis (IPF) [1]. These entities share many
features but are sufficiently different from one another
in terms of their typical histological patterns. Accordingly,
NSIP is further subclassified into cellular (c-NSIP) and
fibrosing (f-NSIP) types [2]. This subtyping is of clinical
importance, because the 5-year survival rate of c-NSIP is
nearly 100 %, while that of f-NSIP is intermediate between
those of c-NSIP and UIP, showing the worst rate among
all of the entities [2]. Although the etiology of IIP remains
enigmatic, there is a growing body of evidence supporting
the theory that alveolar epithelial cell (AEC) injury and
apoptosis contribute to the development and progression
of IIP [3, 4]. In UIP, apoptotic AECs are found in areas of
morphologically unaffected alveoli, suggesting that AEC
apoptosis is a primary event prior to the onset of fibrosis
and subsequently disrupts the basement membrane integ-
rity, leading to various degrees of interstitial responses
characterized by inflammatory cell infiltration and fibro-
blast recruitment [5]. Additionally, apoptosis in AIP is re-
portedly responsible for the resolution of type II AECs
(AECIIs) during the early phase [6]. Molecular pathways
that induce AEC apoptosis have been analyzed mainly in
the setting of UIP or IPF. Intrinsic apoptotic markers
(p53, p21, Bax, and caspase-3) and antiapoptotic markers
(bcl-2) are increased and decreased, respectively, within
AECs [7]. The extrinsic apoptotic factors Fas and Fas lig-
and are upregulated in AECs and infiltrating leukocytes,
respectively [8]. Other mechanisms include increased
oxidative stress products (hydrogen peroxide, myeloper-
oxidase, and nitric oxide) [9, 10], increased endoplasmic
reticulum stress [11], and activation of hypoxia-inducible
factor-1α [12]. Although AEC apoptosis is assumed to be
a key event regardless of the IIP subtype, it remains un-
clear whether there is one AEC apoptosis mechanism
common to all entities versus several mechanisms specific
to each entity.
Cell adhesion molecule 1 (CADM1), also known as
tumor suppressor in lung cancer 1 (TSLC1), is an inter-
cellular adhesion molecule that belongs to the immuno-
globulin (Ig) superfamily [13]. This membrane-spanning
glycoprotein comprises three extracellular Ig-like domains,
a single transmembrane region, and a short carboxy-
terminal intracytoplasmic tail with a protein 4.1 interaction
sequence and a PDZ type II domain-binding motif
[13]. Various types of cells express CADM1, includingpulmonary cells, biliary cells, renal tubular epithelial cells,
neurons, mast cells, and pancreatic endocrine cells [14–17].
In epithelia, CADM1 is located on the lateral cell mem-
brane and mediates neighboring cell–cell adhesion via
trans-homophilic binding [18, 19]. Recent studies have
shown that CADM1 expression is regulated by post-
transcriptional mechanisms, including glycosylation and
proteolytic cleavage, referred to as shedding [20, 21]. The
ectodomain of CADM1 is cleaved at one of two sites,
yielding two membrane-associated C-terminal fragments,
αCTF and βCTF [21]. We recently identified CADM1
shedding as a key event in the development of pulmonary
emphysema, a representative chronic obstructive pulmon-
ary disease characterized by alveolar wall destruction and
enlarged air spaces [22]. CADM1 ectodomain shedding
rates increase in emphysematous lungs, and the mito-
chondrial localization of αCTF contributes to lung epi-
thelial cell apoptosis [22].
In the present study, we evaluated the data of 39 patients
diagnosed with IIP from the autopsy record archive of
Kinki University Hospital and histologically classified them
into four subtypes: AIP, f-NSIP, COP, and UIP. According
to a previously described method [23], protein extracts
were prepared from the autopsied lung paraffin sections
and examined for CADM1 expression by Western blotting.
We found that CADM1 ectodomain shedding increased
and the full-length CADM1 level decreased in IIP lungs,
with statistical significance being different among the
subtypes. We examined whether these alterations in ex-
pression might be involved in AEC apoptosis in IIP,
both in vivo and in vitro. This study identifies CADM1
shedding as a possible pathogenic event common to the
four subtypes of IIP.Methods
Antibodies
A rabbit anti-CADM1 polyclonal antibody directed against
the C-terminal 15-amino acid peptide was generated in
our laboratory as described previously [24]. Other pri-
mary antibodies used targeted cytokeratin 7 (CK7) (mouse
monoclonal OV-TL 12/30; Dako, Glostrup, Denmark),
single-stranded DNA (ssDNA) (rabbit IgG; Immuno-
Biological Laboratories Co., Ltd., Gunma, Japan), thyroid
transcription factor one (TTF1) (mouse monoclonal; Leica
Biosystems, Nussloch, Germany), surfactant protein A
(SP-A) (mouse monoclonal; Leica Biosystems), a cleaved
form of caspase-3 (rabbit polyclonal; Cell Signaling
Technology, Danvers, MA, USA), and glyceraldehyde
3-phosphate dehydrogenase (G3PDH) (Merck Millipore,
Billerica, MA, USA). Peroxidase- and fluorophore-conjugated
secondary antibodies were obtained from Amersham
(Buckinghamshire, England) and Jackson ImmunoResearch
(West Grove, PA, USA), respectively.
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We reviewed the clinical records, autopsy records, and
pathological specimens archived in Kinki University Hos-
pital (Osaka, Japan) to identify autopsied patients who had
been diagnosed with interstitial pneumonia and who had
not received radiation therapy to the lung and had no clin-
ical or histological indications of any diseases causing
secondary interstitial pneumonia, such as collagen and
infectious diseases. Autopsied patients who met these
criteria were considered to have had IIP (n = 36 patients
in the last 10 years, approximately six patients per year).
The control group comprised 10 patients who had died of
diseases without clinical or histological evidence of lung
involvement in the last 10 years (approximately one pa-
tient per year). All patients were autopsied within a couple
of hours after death. Both lungs were removed at autopsy
and fixed with 10 % buffered formalin for several days. A
subpleural segment of the middle portion of each lobe
was then excised, embedded in paraffin, and cut serially
into 20- and 3-μm-thick sections for protein extraction
and histological examination, respectively. Two patholo-
gists (E.E. and A.I.) examined the histologic sections and
classified the IIP-affected lung lobes into AIP, f-NSIP,
COP, and UIP groups according to the updated inter-
national multidisciplinary classification criteria. Three
patients were given different diagnoses in the left and
right lungs (see Additional file 1: Table S1). The Ethics
Committee of Kinki University approved the experimental
protocol (25-088).Protein extraction and western blot analysis
Protein was extracted from 20-μm-thick sections of
paraffin-embedded lungs according to the method de-
scribed by Rodríguez-Rigueiro et al. [25] with minor
modifications [23]. Briefly, each section was deparaffi-
nized by incubation in mineral oil at 95 °C for 2 mins,
and the supernatant was removed by centrifugation at
11320 × g. The pellet was washed serially with phosphate-
buffered saline and citrate-SDS buffer containing 200 mM
Tris–HCl (pH 7.5), 200 mM NaCl, 5 % SDS, and 100 mM
sodium citrate. Protein was extracted from the pellet by
incubation at 100 °C for 20 mins and at 80 °C for 2 h in
citrate-SDS buffer with occasional vortexing, then col-
lected in the supernatant after centrifugation at 11320 × g
for 15 mins at room temperature. The procedures of
protein extraction from cultured cells and Western blot
analyses were performed as described previously [18].
After Western blot transfer, the gels were stained with
Coomassie Brilliant Blue (CBB) to indicate the amount
of protein loading per lane. Immunoreactive band inten-
sities were quantified using ImageJ software (National
Institutes of Health, Bethesda, MD, USA), as described
previously [26].Histological examination
Lung sections (3 μm thick) adjacent to those used for
protein extraction were immunostained as described
previously [18] using primary antibodies against CADM1
and ssDNA. Color reaction and counterstaining were
performed using the peroxidase substrate 3-amino-9-
ethylcarbazole (Vector Labs, Burlingame, CA, USA) and
hematoxylin, respectively. AECIIs were morphologically
identifiable as cuboidal cells >12 μm on a side lining the
lumen of alveoli. AECIIs were often present in the alveo-
lar space, in which case they were rounder in shape, simi-
lar to macrophages. When epithelial-like cell–cell contact
was recognizable between two nonpigmented cells with a
diameter >12 μm, the cells were regarded as AECIIs that
had been detached from the alveolar lumen. Staining for
ssDNA was found to be restricted to the nucleus, and the
positive cells were AECIIs mainly and a few inflammatory
blood cells. For each immunostained section, > 500
AECIIs were randomly selected and individually examined
to determine whether they were positive for ssDNA.
The proportion was calculated by dividing the number
of ssDNA-positive AECIIs by the total cell number. The
means and standard errors (SE) of the proportions were
calculated for each group.Cell culture and transfection
NCI-H441 cells, a human lung epithelial cell line with
characteristics of Clara cells, were purchased from the
American Type Culture Collection (Rockville, MD, USA)
in 2010 (Lot No. 58294188), and all experiments using
this cell line were performed within 6 months after re-
suscitation. NCI-H441 cells were grown as described in
our previous report [22]. A549 cells, a human lung epi-
thelial carcinoma cell line, were described previously
[22]. To silence the expression of CADM1, we constructed
two pSilencer™ 4.1-CMV neo vectors (Applied Biosystems,
Foster City, CA, USA), according to the manufacturer’s
instructions using either of two small interfering RNAs
(siRNAs) specifically targeting human CADM1, i.e.,
siRNA-1, 5′-cgaaagacgtgacagtgat-3′(nt 275–293, num-
bered according to NM_001301043); and siRNA-2, 5′-
ggccctatttagatgataa-3′ (nt 1579–1597), with reference to
our previous report [27]. The negative control pSilencer™
4.1-CMV neo vector (Applied Biosystems) contains a
55-base pair siRNA template with no significant hom-
ology to any mammalian gene. NCI-H441 and A549
cells were grown to 60–70 % confluence and trans-
fected with either siRNA-encoding or control plasmid
vector using Lipofectamine LTX and Plus reagents
(Invitrogen, Carlsbad, CA, USA) according to the man-
ufacturer’s instructions. After 48 h, the transfectants
were subjected to Western blot analyses or assays for
apoptosis detection.
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Terminal deoxynucleotidyl transferase-mediated dUTP
nick end labeling (TUNEL) assays were conducted in
NCI-H441 and A549 cells using the In Situ Cell Death
Detection Kit (Roche Applied Science, Upper Bavarie,
Germany) according to the manufacturer’s instructions,
as described in our previous report [22]. Briefly, the cells
were grown to 60–70 % confluence in μ-Dishes (ibidi,
Verona, WI, USA) and transfected with the indicated
vectors or left untransfected. After 48 h, the cells were
fixed with 4 % paraformaldehyde, permeabilized with
0.1 % Triton X-100 in 0.1 % sodium citrate (pH 7.4), and
incubated with the TUNEL reaction mixture containing
terminal deoxynucleotidyl transferase and FITC-labeled
dUTP for 1 h at 37 °C, followed by nuclear counterstain-
ing with DAPI. Double-stained cultured cells were ob-
served through a fluorescence microscope (Axio Observer
D1; Carl Zeiss). When a cell exhibited TUNEL signals
within the DAPI nuclear stain, the cell was deemed
TUNEL-positive. The number of TUNEL-positive cells
was counted among 500 NCI-H441or A549 cells. All
measurements were performed in triplicate, and the
mean and SE of the proportion of TUNEL-positive cells
were calculated for each experimental group. The TUNEL
assays were repeated three times with essentially similar
results. Another set of H441 cells was fixed with 4 % para-
formaldehyde, treated with 1.0 % bovine serum albumin
and 0.3 % Triton X-100 in phosphate-buffered saline, and
immunostained with an antibody against a cleaved form
of caspase-3 and a Cy3-conjugated secondary antibody.
The proportion of cleaved caspase-3-positive cells was cal-
culated as described above for TUNEL assays.
Double staining
Double immunofluorescence of lung sections was per-
formed as described previously [22]. Sections were incu-
bated with a mixture of antibodies against ssDNA and
SP-A, and then reacted with Alexa Flour 488- and 594-
conjugated secondary antibodies. Double staining of lung
sections for two apoptotic markers ssDNA and TUNEL
was performed as described previously [22]. Sections were
first stained with a Click-iT Plus TUNEL Assay Kit
containing an Alexa Flour 488-conjugated secondary
antibody (Molecular Probes, Eugene, OR, USA) accord-
ing to the manufacturer’s instructions, and were next
immunostained with the anti-ssDNA antibody, followed
by reaction with an Alexa Flour 594-conjugated secondary
antibody. The percentage of double-positive cells among
200 ssDNA-positive AECIIs was calculated for each case.
Statistical analysis
Clinical variables of autopsied patients were assessed be-
tween any two groups using the Steel–Dwass test for age
and the χ2 test for sex. Statistical differences betweenany two groups were analyzed using the Steel–Dwass
test to assess the quantified Western blot data and the
proportions of AECIIs. Correlations were analyzed using
Spearman’s rank test. For in vitro studies, the quantified
Western blot data and TUNEL-positive cell proportions
were compared using Student’s t-test. A P-value ≤ 0.05
was considered statistically significant.
Results
Increased ectodomain shedding of CADM1 in IIP lungs
Thirty-nine lung lobes from 36 autopsied patients with
IIP were classified into four groups: AIP (n = 10), f-NSIP
(n = 10), COP (n = 9), and UIP (n = 10). The patients’
characteristics are summarized in Additional file 1:
Table S1. Including the control group, there was no dif-
ference in age or sex between any two groups. We ex-
tracted protein from peripheral lung parenchyma sections
and analyzed the extracts by Western blotting using a
CADM1 antibody (Fig. 1a and Additional file 2: Figure S1).
Consistent with our previous report [22], the CADM1 anti-
body detected three forms of CADM1 approximately 100,
35, and 18 kDa in size, corresponding to full-length
CADM1, βCTF, and αCTF, respectively (Fig. 1a and
Additional file 2: Figure S1). The CADM1 shedding
rates were calculated as the band intensities of αCTF,
βCTF, and αCTF + βCTF relative to that of full-length
CADM1 and designated the α-, β-, and (α + β)-shedding
rates, respectively. All four IIP groups had higher α-shedding
rates than those of the control group, while there was
no significant difference in the β-shedding rate between
any two groups (Fig. 1b). The (α + β)-shedding rate in
f-NSIP lungs was the highest, with significant differences
from both the control and UIP groups (Fig. 1b).
We previously reported that CADM1 distributed ex-
clusively to bronchial and alveolar epithelial cells in the
human peripheral lung parenchyma [14]. Thus, epithelial
cells were considered to be the major cell source of
CADM1. The Western blots were reprobed using an anti-
body to CK7 (a lung epithelial marker) [28], and full-length
CADM1 expression per epithelial cell was estimated by
normalizing the band intensity of CADM1 to CK7 (Fig. 1a
and Additional file 2: Figure S1). Some samples did
not give a clear single band for CK7 (Additional file 2:
Figure S1) and were thus excluded from further ana-
lyses (control, n = 10; AIP, n = 10; f-NSIP, n = 9; COP,
n = 5; and UIP, n = 9) (Additional file 1: Table S1). On
average, the full-length CADM1 level per epithelial cell
was lower in all four IIP groups than in the control group,
but the decrease was statistically significant only in the
f-NSIP group (Fig. 1c).
A scatter plot of all cases and Spearman correlation
analyses revealed that the full-length CADM1 level per
epithelial cell was inversely correlated with the α-shedding
rate (Fig. 1d), suggesting that increased α-shedding
Fig. 1 (See legend on next page.)
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Fig. 1 Western blot analysis of CADM1 expression in IIP lungs. a Protein was extracted from control and IIP lung sections and subjected to Western
blot analyses using an anti-CADM1 antibody. Cases are numbered as in Additional file 1: Table S1. Results of the remaining cases are shown in
Additional file 2: Figure S1. Arrowheads indicate bands corresponding to the full-length, αCTF, and βCTF forms of CADM1. The blot was
reprobed with an anti-CK7 and anti-TTF1 antibody to estimate the number of epithelial cells and AECIIs, respectively. An asterisk indicates the
sample that did not gave a clear immunoreactive band for TTF1. After Western blot transfer, the gels were stained with CBB to indicate the
amount of protein loading per lane. b CADM1 ectodomain shedding rates (amount of CTFs relative to full-length CADM1) and c full-length
CADM1 level per lung epithelial cell (relative to CK7) in each patient sample are plotted as dots. Statistical significance between two groups
was analyzed using the Steel–Dwass test. P-values≤ 0.05 are shown. d The full-length CADM1 level per epithelial cell with the CADM1α-shedding rate
is shown in a scatter plot, and the dot distribution approximates a linear function (dotted line). Correlations and statistical significance were analyzed
using Spearman’s rank test. R2 and P-values are shown
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CADM1 in lung epithelial cells of patients with IIP.
Correlation between CADM1 shedding and AECII
apoptosis in IIP
The lung sections were immunostained with an antibody
targeting ssDNA to detect apoptotic cells [29] and coun-
terstained with hematoxylin, which allowed morphological
identification of AECIIs (Fig. 2a). Apoptotic AECIIs were
clearly detected as cells double positive for ssDNA and
SP-A, a AECII marker, by double immunofluorescence in
all four IIP subtypes (Fig. 2b). The proportion of ssDNA-
positive AECIIs was practically zero in the control lungs,
whereas it was significantly increased in all four IIP groups
(Fig. 2c). The scatter plot and Spearman correlation
analyses revealed that this proportion was correlated
positively with the α- and (α + β)-shedding rates and in-
versely with the full-length CADM1 level per epithelial
cell (Fig. 2d, and Additional file 3: Figure S2, A and B). In
IIP lungs, AECIIs were often detached from the alveolar
wall (Fig. 2a). Because some were ssDNA-positive but
others ssDNA-negative, these detached cells were con-
sidered to be dead due to apoptosis including anoikis
or other mechanisms including necrosis [30]. Some
AECIIs were both ssDNA-positive and detached.
CADM1 expression in IIP lungs was examined by im-
munohistochemistry. In AECIIs lining the alveolar lumen,
CADM1 was detected primarily on the lateral membrane,
which is the proper localization for full-length CADM1
[14], regardless of the IIP subtype (Fig. 3 and Additional
file 4: Figure S3). In contrast, CADM1 membranous stain-
ing rarely occurred in AECIIs that were detached or
detaching from the wall; instead, intracytoplasmic staining
was often noticeable (Fig. 3). This probably reflects de-
creased full-length CADM1 levels and increased produc-
tion of αCTF due to increased α-shedding, as shown in
emphysematous lungs [22]. AECIIs with this staining pat-
tern were predominantly observed in f-NSIP lungs. These
results provide histologic evidence of a relationship of
AECII apoptosis with increased α-shedding and decreased
full-length CADM1 levels. To gain further evidence for
this relationship, we reprobed the Western blot of lung
tissues with an antibody against TTF1, a AECII marker(Fig. 1a and Additional file 2: Figure S1). When the full-
length CADM1 level was normalized to TTF1, it had a
propensity to inversely correlate with the percentage of
ssDNA-positive AECIIs but did not reach statistical sig-
nificance (Additional file 3: Figure S2C), probably due
to varying proportions of AECIIs in individual lung sec-
tions. In addition, we assessed AECII apoptosis by double
immunofluorescence using TUNEL as a second apop-
tosis marker in two or three cases for each IIP subtype
(Additional file 5: Figure S4). More than 80 % of ssDNA-
positive AECIIs were positive for TUNEL, confirming the
validity of ssDNA immunohistochemistry.
Increased apoptosis of lung epithelial cells by CADM1-
targeting siRNA
NCI-H441 human lung epithelial cells were transfected
with a plasmid vector encoding either specific siRNA
targeting CADM1 (siRNA-1 and -2) or control siRNA.
After 48 h, the cells were subjected to Western blot
analyses using antibodies to CADM1 and G3PDH. Full-
length CADM1 levels were normalized to G3PDH levels.
CADM1-targeting siRNA-1 and -2 reduced the level of
full-length CADM1 by approximately 61 and 43 %, re-
spectively, while control siRNA had no effect on the level
(Fig. 4a and b). Another set of transfectants was examined
for frequency of apoptosis by TUNEL assays. The per-
centage of TUNEL-positive cells was around 1 % in un-
treated cells and control siRNA transfectants but
approximately 18 and 5 % in CADM1-targeting siRNA-
1 and -2 transfectants (P ≤ 0.024) (Fig. 4c and Additional
file 6: Figure S5A). Consistent results were obtained when
apoptosis was detected by immunohistochemistry using
an antibody against cleaved caspase-3, a key apoptosis
effector [31] (Additional file 6: Figure S5B). Experiments
were repeated using A549 human lung epithelial cells,
with results essentially similar to those of H441 cells
(Additional file 7: Figure S6).
Discussion
In the present study, we examined CADM1 expression in
four histologic subtypes of IIP and found that CADM1
α-shedding was increased in all four subtypes and that
the full-length CADM1 level was decreased in f-NSIP.
Fig. 2 (See legend on next page.)
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Fig. 2 Correlation between AECII apoptosis and CADM1 ectodomain shedding in IIP. a Control and IIP lung sections were stained immunohistochemically
with an anti-ssDNA antibody and counterstained with hematoxylin. A representative photomicrograph for each group is shown. Arrows
indicate AECIIs detached from the alveolar wall. Arrowheads indicate ssDNA-positive inflammatory blood cells, as opposed to AECIIs. Bar = 50 μm. b IIP
lung sections were double immunostained with antibodies against ssDNA (green) and SP-A (red), and counterstained with DAPI (blue). A representative
result for each subtype is shown as a picture where the three fluorescence images are merged. Arrows indicate cells double positive for ssDNA and SP-A.
Bar = 25 μm. c Proportions of ssDNA-positive AECIIs in each patient sample are plotted as dots, and statistical significance between two groups
was analyzed using the Steel–Dwass test. P-values ≤ 0.05 are shown. d The proportion of ssDNA-positive AECIIs with the CADM1 α-shedding
rate (left) and the full-length CADM1 level per epithelial cell (right) are shown in a scatter plot. In each graph, the dot distribution approximates
a linear function (dotted lines). Correlations and statistical significance were analyzed using Spearman’s rank test. R2 and P-values are shown
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the full-length CADM1 level were correlated with one
another and with the proportion of ssDNA-positive
AECIIs, suggesting a significant contribution of CADM1
shedding to AECII apoptosis in IIP lungs. Two mecha-
nisms for these phenomena are proposed. One involves
αCTF, an α-shedding product of CADM1. As we previ-
ously showed in emphysematous lungs, once αCTF is
produced in AECIIs, it accumulates preferentially in the
mitochondria and consequently depolarizes the mito-
chondrial membrane potential, resulting in activation of
the mitochondrial apoptotic pathway in AECIIs [22].
As shown in Fig. 3, CADM1 was often detected in the
cytoplasm, but not on the cell membrane, of detaching
AECIIs, suggesting accumulation of αCTF in the mito-
chondria. The notion that the mitochondrial apoptotic
pathway is activated in IIP lung epithelial cells was de-
scribed as early as 2002 by Kuwano et al. [32]. The
present study reinforces this notion and proposes αCTF
as a key molecule in the activation of this pathway. An-
other mechanism involves the decrease in full-length
CADM1 levels as a result of increased CADM1 shed-
ding. As evidenced by the siRNA transfection experi-
ment, decreased full-length CADM1 expression in lung
epithelial cells appeared to be associated with increased
apoptosis. We previously performed similar experiments
and reported that downregulation of CADM1 by siRNA
abrogates the formation of epithelial cell structure,Fig. 3 Immunohistochemical analysis of CADM1 in IIP lungs. IIP lung sectio
and counterstained with hematoxylin. Representative results for f-NSIP and
localizations of CADM1 in AECIIs that are lining the alveolar lumen (a, c and e
Results of the other subtypes are shown in Additional file 4: Figure S3suggesting an essential role for full-length CADM1 in
the maintenance of epithelial cell polarity [33]. Because
loss of cell polarity can trigger apoptosis to eliminate dam-
aged epithelial cells [34, 35], full-length CADM1 downreg-
ulation supposedly causes AECII apoptosis through loss of
epithelial polarity. Considering the present Western blot
data, these two mechanisms may contribute differently
to the pathogenesis of individual IIP subtypes; the αCTF
mechanism profoundly impacts AIP, f-NSIP, and COP
and relatively mildly impacts UIP, while the full-length
CADM1 mechanism acts particularly on f-NSIP.
Among the four IIP subtypes examined, f-NSIP was
notable, because it exhibited the highest shedding rates
and expressed the lowest level of full-length CADM1
per epithelial cell, suggesting strong involvement of
CADM1 shedding in the pathogenesis of f-NSIP. NSIP
has some degree of overlap with a variety of other IIP
subtypes [2]. Yang et al. [36] examined the gene expres-
sion profiles of NSIP and UIP and concluded that the
two entities are similar transcriptionally. However, they
identified eight transcripts that best differentiate the two,
including the serine protease cathepsin G gene, which
was upregulated in NSIP [36]. Another study by Takahashi
et al. [37] reported that matrix metalloproteinase-2
(MMP-2) mRNA levels are higher in NSIP than in UIP.
The fact that these two proteases are released from neu-
trophils and macrophages [38, 39] is consistent with our
clinical experiences showing that NSIP behaves as a morens were stained immunohistochemically with an anti-CADM1 antibody
UIP are shown. Boxed areas are enlarged to depict different subcellular
), detaching (d and e), or detached (b) from the alveolar wall. Bar = 50 μm.
Fig. 4 Increased apoptosis of NCI-H441 cells transfected with an siRNA targeting CADM1. a NCI-H441 cells were left untreated (–) or transfected
with control or CADM1-targeting siRNA (siRNA-1 and -2). After 48 h, CADM1 expression was examined by Western blot analyses. The blot was
reprobed using an anti-G3PDH antibody to normalize full-length CADM1 levels to G3PDH. After Western blot transfer, the gels were stained with
CBB to indicate the amount of protein loading per lane. b The relative CADM1 levels were further normalized to a value of 1 in untreated cells, to
which the CADM1 levels in transfectants were then normalized. The mean ± SE full-length CADM1 levels were calculated from triplicate experiments
for each cell type, and statistical significance was analyzed using Student’s t-test. P-values≤ 0.05 are shown. c Another set of NCI-H441 cells untreated
and transfected with either control or siRNA-1 vector was analyzed by TUNEL assays. In the upper column, TUNEL (green) and DAPI (blue) fluorescent
images were merged. The differential interference contrast images are shown on the lower. Bar = 50 μm. The mean proportions of TUNEL-positive
cells and the SE were indicated under the panels. P-values ≤ 0.05 by Student’s t-test are shown. Results of siRNA-2 transfectants are shown in
Additional file 6: Figure S5
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Both cathepsin G and MMP-2, once released, are exe-
cuters of ectodomain shedding of Ig superfamily adhesion
molecules, such as ICAM-1 or 5 and VCAM-1 expressed
on bone marrow cells or neurons [40–42]. The particu-
larly increased CADM1 shedding in f-NSIP may be attrib-
utable to the high expression levels of these proteases.
The f-NSIP group also differed substantially from the
UIP group with respect to the incidence of AECII apop-
tosis. Some previous studies have demonstrated that in
UIP, AECII apoptosis occurs actively in morphologically
unaffected lung parenchyma around the remodeled fibrotic
lesion, but only occasionally within the fibrotic lesion,
where the percentage of apoptotic AECIIs is approximately
1–5 % (in contrast, it is practically 0 % in the normal lung)
[5, 32, 43]. These values are consistent with our histological
findings in the UIP fibrotic lesions and control lungs. Only
a few referable studies on NSIP are available; these studies
reported that 1-2 % of AECIIs were apoptotic in NSIP
(whether the cellular or fibrosing subtype was not spe-
cified) [32, 43]. Compared with this estimation, our
measured values (10.4 ± 3.8 %) are quite high. This may
represent a limitation of the present study, as we analyzed
only autopsied cases. This sampling method might have
introduced significant bias in the patient pool composi-
tions. In fact, six of ten patients in the f-NSIP group and
three of nine patients in the COP group died of IIP itself,
although these IIP entities reportedly have fairly good
5-year survival rates [2]. Our f-NSIP and COP groups
may have comprised more patients with severe pathophysi-
ology. Another interpretation of the present results is that
active AECII apoptosis may contribute to treatment resist-
ance and poor prognoses in patients with f-NSIP and COP.
Among the four subtypes, the incidence of AECII apop-
tosis was the highest in AIP, which is consistent with
several past studies [6, 44]. Serial activation of macro-
phages and neutrophils has long been believed to be an
important pathogenic process for AECII injury in AIP, but
how these cells act on AECIIs is not entirely clear. When
activated, these inflammatory cells potently release a
variety of products, including proteases such as cathepsin
G and MMP-2, as described above. Inflammatory cell in-
filtration may cause local increases in proteolytic activities
and thereby promote AECII apoptosis by increasing
CADM1 shedding in AIP lungs.
In conclusion, the present study demonstrated a close
link between increased CADM1 ectodomain shedding and
increased AECII apoptosis in IIP and suggests a patho-
physiologic commonality between IIP and pulmonary
emphysema at the molecular level. Following our previ-
ous characterization of CADM1 as a human pancreatic
islet cell adhesion molecule involved in hormone secre-
tion [18], we recently found that CADM1 shedding was
increased in type two diabetes mellitus pancreata andinvolved in β cell apoptosis [23]. Taken together, our
findings indicate that CADM1 shedding may trigger
apoptosis in cells that require CADM1 to fulfill their
proper function. Although the precise mechanisms of
increased CADM1 shedding in individual diseases re-
main to be clarified, it is noteworthy that ectodomain
shedding is a proteolytic process mediated by proteases.
As shown in pulmonary emphysema [22], protease-over-
antiprotease activity imbalance may be a precedent key
event in lesions in which CADM1-expressing cell apop-
tosis occurs. Although this study identified the molecular
distinctions among IIP subtypes, it also suggests that IIP,
regardless of the subtype, may share a pathogenic molecu-
lar process with more common diseases, such as type two
diabetes mellitus and pulmonary emphysema.Additional files
Additional file 1: Table S1. Characteristics of autopsied patients
(DOCX 26 kb)
Additional file 2: Figure S1. Western blot analysis of CADM1 expression
in IIP lungs. Protein was extracted from control and IIP lung sections and
subjected to Western blot analyses using an anti-CADM1 antibody. Cases
are numbered as in Additional file 1: Table S1. Arrowheads indicate bands
corresponding to the full-length, αCTF, and βCTF forms of CADM1. The blot
was reprobed with an anti-CK7 and anti-TTI1 antibody to estimate the
number of epithelial cells and AECIIs, respectively. Asterisks indicate the
samples that did not gave a clear immunoreactive band for CK7 or
TTF1. After Western blot transfer, the gels were stained with CBB to indicate
the amount of protein loading per lane. (TIFF 1277 kb)
Additional file 3: Figure S2. Correlations of the full-length CADM1 level
per epithelial cell or AECII apoptosis with (α + β)-shedding rate in IIP.
(A) The full-length CADM1 level per epithelial cell with the CADM1 (α + β)-
shedding rate are shown in a scatter plot. (B and C) The proportion of
ssDNA-positive AECIIs with the CADM1 (α + β)-shedding rate (B) and
the full-length CADM1 level normalized to TTF1 (C) are shown in scatter
plots. In each graph A, B and C, the dot distribution approximates a linear
function (dotted lines). Correlations and statistical significance were analyzed
using Spearman’s rank test. R2 and P-values are shown. (TIFF 208 kb)
Additional file 4: Figure S3. Immunohistochemical analysis of CADM1
in IIP lungs. IIP lung sections were stained immunohistochemically with an
anti-CADM1 antibody and counterstained with hematoxylin. Representative
results for control lungs, AIP and COP are shown. Boxed areas are enlarged
to depict different subcellular localizations of CADM1 in epithelial cells that
are lining the alveolar lumen (a, b and f), detaching (e and g), or detached
(c and d) from the alveolar wall. Bar = 50 μm. (TIFF 2572 kb)
Additional file 5: Figure S4. Double staining of IIP lungs for two
apoptosis markers, ssDNA and TUNEL. IIP lung sections from the cases
indicated were stained serially using the TUNEL methods (green) and
ssDNA immunofluorescence (red), and then reacted with DAPI (blue) to
stain the nucleus. Representative results from the cases indicated by
asterisks are shown as pictures where the three fluorescence images are
merged. White signals indicate the nuclei double positive for ssDNA and
TUNEL. Some nuclei are single positive for either marker depicted by
arrows. The proportions of double-positive cells among ssDNA-positive
AECIIs (concordance rate) are shown in the rightmost column. Bar = 50 μm.
(TIFF 1437 kb)
Additional file 6: Figure S5. Increased apoptosis of NCI-H441 cells
transfected with a CADM1 siRNA-2 vector. (A) NCI-H441 cells were untreated
or transfected with either control or CADM1 siRNA-2 vector, as described in
Fig. 4, and then were analyzed by TUNEL assays. In the upper column, TUNEL
(green) and DAPI (blue) fluorescent images were merged. The differential
interference contrast images are shown on the lower. (B) Another set of
Yoneshige et al. Respiratory Research  (2015) 16:90 Page 11 of 12NCI-H441 cells untreated and transfected with either control or CADM1
siRNA-2 vector was stained by immunofluorescence for cleaved caspase-3.
In the upper column, cleaved caspase-3 (red) and DAPI (blue) fluorescent
images were merged. The differential interference contrast images are
shown on the lower. The mean proportions of TUNEL-positive cells and the
SE were indicated under the panels. P-values≤ 0.05 by Student’s t-test are
shown. Bar = 50 μm. (TIFF 3101 kb)
Additional file 7: Figure S6. Increased apoptosis of A549 cells transfected
with an siRNA targeting CADM1. (A) A549 cells were left untreated (–) or
transfected with control or CADM1-targeting siRNA (siRNA-2). After 48 h,
CADM1 expression was examined by Western blot analyses. The blot was
reprobed using an anti-G3PDH antibody to normalize full-length CADM1
levels to G3PDH. After Western blot transfer, the gels were stained with CBB
to indicate the amount of protein loading per lane. (B) The relative CADM1
levels were further normalized to a value of 1 in untreated cells, to
which the CADM1 levels in transfectants were then normalized. The
mean ± SE full-length CADM1 levels were calculated from triplicate
experiments for each cell type, and statistical significance was analyzed
using Student’s t-test. P-values≤ 0.05 are shown. (C) Another set of A549
cells untreated and transfected with either control or siRNA-2 vector
was analyzed by TUNEL assays. In the upper column, TUNEL (green)
and DAPI (blue) fluorescent images were merged. The differential
interference contrast images are shown on the lower. Bar = 50 μm. The
mean proportions of TUNEL-positive cells and the SE were indicated under
the panels. P-values≤ 0.05 by Student’s t-test are shown. (TIFF 1716 kb)
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